List of insiders holdings for Arcus Biosciences Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
GILEAD SCIENCES INC. 10% Owner | 2024-01-31 17:00:35 | 30,061,124 0 | 30,061,124 | Form 4 |
ROSEN TERRY J Chief Executive Officer | 2024-01-25 19:39:26 | 4,372,874 0 | 4,372,874 | Form 4 |
GV 2016 GP L.L.C. GV 2016 GP L.P. GV 2016 L.P. Alphabet Inc. 10% Owner | 2022-02-14 12:30:53 | 2,563,441 0 | 2,563,441 | Form 13G |
GV 2017 GP L.L.C. GV 2017 GP L.P. GV 2017 L.P. Alphabet Inc. 10% Owner | 2018-03-19 17:28:00 | 0 1,924,474 | 1,924,474 | Form 4 |
Jaen Juan C. President | 2024-02-28 19:55:43 | 341,475 1,188,233 | 1,529,708 | Form 4 |
Hadley Harbor Master Investors (Cayman) II L.P. 10% Owner | 2018-03-19 18:22:57 | 1,496,813 0 | 1,496,813 | Form 4 |
KANEKO YASUNORI Director | 2023-06-16 20:03:36 | 26,300 903,755 | 930,055 | Form 4 |
Hemrajani Rekha See Remarks | 2019-03-25 18:54:24 | 400,000 0 | 400,000 | Form 4 |
Tang Carolyn C. General Counsel | 2024-01-25 19:39:38 | 222,779 0 | 222,779 | Form 4 |
Jarrett Jennifer Chief Operating Officer | 2024-03-29 16:20:31 | 215,253 0 | 215,253 | Form 4 |
Nuyten Dimitry SA Chief Medical Officer | 2024-01-25 19:38:55 | 212,895 0 | 212,895 | Form 4 |
FALBERG KATHRYN E Director | 2023-06-16 20:01:59 | 66,400 102,106 | 168,506 | Form 4 |
Goeltz II Robert C. Chief Financial Officer | 2024-02-23 17:49:44 | 73,831 0 | 73,831 | Form 4/A |
Lacey David L. Director | 2023-06-16 20:08:18 | 68,752 0 | 68,752 | Form 4 |
Ribas Antoni Director | 2023-06-16 20:06:48 | 41,450 8553 | 50,003 | Form 4 |
PERLMAN ANDREW J Director | 2023-06-16 20:09:56 | 40,425 0 | 40,425 | Form 4 |
Machado Patrick Director | 2023-06-16 20:05:13 | 36,400 0 | 36,400 | Form 4 |
Lambert Nicole Director | 2023-06-16 20:11:09 | 35,100 0 | 35,100 | Form 4 |
BEIER DAVID W Director | 2019-06-10 14:59:56 | 35,000 0 | 35,000 | Form 4 |
Hege Kristen Director | 2019-06-10 15:07:50 | 35,000 0 | 35,000 | Form 4 |
Chan Steven See Remarks | 2019-01-18 13:25:27 | 35,000 0 | 35,000 | Form 4 |
Azoy Alexander Chief Accounting Officer | 2024-01-25 19:39:50 | 24,970 0 | 24,970 | Form 4 |
Grossman William Chief Medical Officer | 2021-06-21 16:48:59 | 20,723 0 | 20,723 | Form 4 |
Barker Jason See Remarks | 2020-06-08 16:22:44 | 10000 0 | 10000 | Form 4 |
Higgins Linda Slanec Director | 2021-08-13 17:10:53 | 0 0 | 0 | Form 3 |
Quigley Michael Director | 2021-01-06 16:20:26 | 0 0 | 0 | Form 3 |
Mercier Johanna Director | 2024-02-07 18:58:17 | 0 0 | 0 | Form 3 |
Parsey Merdad Director | 2020-07-13 17:59:55 | 0 0 | 0 | Form 3 |
COLUMN GROUP II LP Column Group II GP LP Ponoi Management LLC PONOI CAPITAL LP GOEDDEL DAVID V Svennilson Peter Kutzkey Tim 10% Owner | 2020-11-04 16:52:30 | 0 0 | 0 | Form 13G |